Skip to main content

Market Overview

12 Health Care Stocks Moving In Wednesday's Intraday Session

Share:

 

Gainers

  • Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is trading at a volume of 171.7 million, which is 35592.47% of its average full-day volume over the last 100 days. The company's market cap stands at $120.0 million.
  • Checkpoint Therapeutics (NASDAQ:CKPT) stock moved upwards by 22.93% to $3.27. The current volume of 19.9 million shares is 2288.52% of Checkpoint Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $258.9 million.
  • Clovis Oncology (NASDAQ:CLVS) shares moved upwards by 16.19% to $6.63. As of 12:30 EST, Clovis Oncology's stock is trading at a volume of 34.8 million, which is 334.71% of its average full-day volume over the last 100 days. The company's market cap stands at $693.7 million.
  • Altimmune (NASDAQ:ALT) shares increased by 15.2% to $16.06. As of 12:30 EST, this security is trading at a volume of 1.0 million shares, making up 92.37% of its average full-day volume over the last 100 days. The company's market cap stands at $616.6 million.
  • Inovio Pharmaceuticals (NASDAQ:INO) stock increased by 14.55% to $9.84. The current volume of 14.7 million shares is 175.16% of Inovio Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $2.0 billion.
  • Nemaura Medical (NASDAQ:NMRD) shares increased by 13.62% to $15.99. As of 12:30 EST, Nemaura Medical's stock is trading at a volume of 234.4K, which is 12.97% of its average full-day volume over the last 100 days. The company's market cap stands at $366.5 million.

 

 

Losers

 

  • Atossa Therapeutics (NASDAQ:ATOS) shares fell 23.23% to $4.66 during Wednesday's regular session. Atossa Therapeutics's stock is trading at a volume of 38.5 million shares as of 12:30 EST. This is 300.11% of its average full-day volume over the last 100 days. The company's market cap stands at $563.0 million.
  • Precipio (NASDAQ:PRPO) shares decreased by 10.02% to $3.75. Trading volume for Precipio's stock is 2.6 million as of 12:30 EST. This is 18.64% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.2 million.
  • Aclaris Therapeutics (NASDAQ:ACRS) stock declined by 9.71% to $16.94. As of 12:30 EST, this security is trading at a volume of 830.5K shares, making up 133.06% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $882.6 million.
  • Hims & Hers Health (NYSE:HIMS) stock declined by 9.21% to $13.94. As of 12:30 EST, this security is trading at a volume of 630.0K shares, making up 37.29% of its average full-day volume over the last 100 days.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock decreased by 8.09% to $1.53. Trading volume for this security as of 12:30 EST is 1.6 million, which is 73.01% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $182.8 million.
  • Second Sight Medical (NASDAQ:EYES) stock declined by 7.94% to $6.21. As of 12:30 EST, this security is trading at a volume of 2.1 million shares, making up 14.25% of its average full-day volume over the last 100 days. The company's market cap stands at $173.1 million.

 

 

 

Related Articles (ACRX + ACRS)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com